Cancer
The latest in cancer treatments: Recreating the tumor environment
April 28 by Leila HawkinsPharma IQ speaks to HCS Pharma about creating the technology that reproduces tumor microenvironments to treat cancer
Rewriting the human genome
March 15 by Pharma IQFind out how the CRISPR market is developing and why it's influential to the world as we know it.
Prostate cancer in Scotland: an evolutionary journey
March 25 by Pharmaceuticals & Biotechnology EditorKaren Walker, Clinical Nurse Specialist at Edinburgh Cancer Center shares this case study
UCI announces immunotherapy technique to specifically target tumor cells
November 12 by Pharmaceuticals & Biotechnology EditorUCI and Caltech's latest "lab on a chip" technology could be used to create individualized treatments for cancer
Repositive connects oncologists with cancer models
October 10 by Pharma IQ NewsRepositive launches limited-time free Personal Shopper Service, to connect researchers with difficult-to-source translational cancer models
A new study from California’s Buck Institute for Research on Aging finds that cancer treatments should depend on the type of tumour
July 10 by Pharmaceuticals & Biotechnology EditorCancers should be treated depending on the type of tumour they are, and not on where they are first found in the body, according to a ground-breaking new study.
The Ascent of Precision Medicines
May 17 by Pharmaceuticals & Biotechnology EditorTraditionally the pharma industry has lent towards the view of a one-size fits all approach to the application of therapeutics. Now, eyes are set firmly on the notion of personalised medicine – therap...
The R&D Race behind Immune Checkpoint Modulators
November 14 by Chanice HenryThe cancer immunotherapy market is primed for growth, with Immune Checkpoint Inhibitors, otherwise known as Immune Checkpoint Modulators, representing one of the area’s newest and most promising treat...
Epigenetics Market to climb to $16.3bn
October 30 by Chanice HenryA new research report from Grand View Research inc, charts that the international epigenetics market is due to reach US$16.31 billion by 2022. The forecasted growth being fuelled by the increasing f...
Best in Class Case Study- Big Data & Cancer Research
June 25 by Pharmaceuticals & Biotechnology EditorAs of now, big data is not utilised as often and as well as it could be in the Pharmaceutical Industry.Data usage could lead to accelerated drug discovery and better help patients, enabling c...
AstraZeneca Leads the Way for PARP-inhibitor Ovarian Cancer Treatments
September 11 by Pharma IQ NewsNew targeted therapies in race for approval Pharma giant AstraZeneca is currently leading the way in the development of a new PARP (poly ADP-ribose polymerase) inhibitor for the treatment of ovari...
Angelina Jolie and the Maturity of Genomics
May 16 by Gerald ClarkeThe extraordinary and brave decision of Angelina Jolie to publish an op-ed in the New York Times about her decision to undergo a preventative double mastectomy in response to learning that she carri...